CURE vs. SOXS
CURE (Direxion Daily Healthcare Bull 3x Shares) and SOXS (Direxion Daily Semiconductor Bear 3x Shares) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while SOXS is a Inverse Equities fund tracking the PHLX Semiconductor Index (-300%). Both are passively managed. Over the past 10 years, CURE returned 13.82%/yr vs -78.37%/yr for SOXS. At a correlation of -0.45, they often move in opposite directions. Both charge a 1.08% expense ratio.
Performance
CURE vs. SOXS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a 6.23% return, which is significantly higher than SOXS's -91.53% return. Over the past 10 years, CURE has outperformed SOXS with an annualized return of 13.82%, while SOXS has yielded a comparatively lower -78.37% annualized return.
CURE
- 1D
- 6.20%
- 1M
- 17.48%
- 6M
- 2.51%
- YTD
- 6.23%
- 1Y
- 54.41%
- 3Y*
- 8.53%
- 5Y*
- 2.31%
- 10Y*
- 13.82%
SOXS
- 1D
- 13.14%
- 1M
- 13.65%
- 6M
- -87.79%
- YTD
- -91.53%
- 1Y
- -96.24%
- 3Y*
- -84.87%
- 5Y*
- -79.52%
- 10Y*
- -78.37%
CURE vs. SOXS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 6.23% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
SOXS Direxion Daily Semiconductor Bear 3x Shares | -91.53% | -85.53% | -59.55% | -84.56% | 15.76% | -80.94% | -92.90% | -83.81% | -19.39% | -69.39% |
Correlation
The correlation between CURE and SOXS is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.30 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.39 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | -0.45 |
Over the past year, the inverse relationship between CURE and SOXS has weakened: their correlation has moved from -0.45 to -0.02, meaning they move in opposite directions less often than they have historically.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. SOXS — Risk / Return Rank
CURE
SOXS
CURE vs. SOXS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Semiconductor Bear 3x Shares (SOXS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | SOXS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.93 | ||
| Sortino ratioReturn per unit of downside risk | +4.55 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 0.72 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 1.76 | -0.98 | +2.74 |
| Martin ratioReturn relative to average drawdown | 3.91 | -1.41 | +5.32 |
Loading charts...
Drawdowns
CURE vs. SOXS - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum SOXS drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for CURE and SOXS.
Loading charts...
Drawdown Indicators
| CURE | SOXS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -100.00% | +30.81% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -97.89% | +66.79% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -99.87% | +47.94% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -99.98% | +47.75% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -100.00% | +30.81% |
Current DrawdownCurrent decline from peak | -15.68% | -100.00% | +84.32% |
Average DrawdownAverage peak-to-trough decline | -18.17% | -92.63% | +74.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.95% | 68.36% | -54.41% |
Volatility
CURE vs. SOXS - Volatility Comparison
The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 18.67%, while Direxion Daily Semiconductor Bear 3x Shares (SOXS) has a volatility of 59.41%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than SOXS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | SOXS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.67% | 59.41% | -40.74% |
Volatility (6M)Calculated over the trailing 6-month period | 34.60% | 109.76% | -75.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.78% | 126.44% | -79.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.55% | 113.26% | -68.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.74% | 103.02% | -53.28% |
CURE vs. SOXS - Expense Ratio Comparison
Both CURE and SOXS have an expense ratio of 1.08%.
Dividends
CURE vs. SOXS - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.07%, less than SOXS's 43.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.07% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
SOXS Direxion Daily Semiconductor Bear 3x Shares | 43.65% | 10.79% | 5.45% | 9.22% | 0.19% | 0.00% | 3.58% | 2.30% | 0.76% | 0.00% |
Frequently Asked Questions
CURE and SOXS have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SOXS has higher volatility (59.41%) compared to CURE (18.67%). In terms of maximum drawdown, CURE dropped -69.19% vs SOXS's -100.00%.
On 10-year performance, CURE leads with 13.82% vs -78.37% for SOXS. Both ETFs have the same 1.08% expense ratio. On volatility, CURE has been the lower-risk option at 18.67%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.82% return vs -78.37%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CURE and SOXS have the same expense ratio: 1.08% per year.
SOXS has the higher dividend yield at 43.65%, compared with 1.07% for CURE.
CURE is categorized as Leveraged Equities, while SOXS is Inverse Equities. CURE tracks Health Care Select Sector Index (300%), while SOXS tracks PHLX Semiconductor Index (-300%).
CURE currently has the higher Sharpe Ratio (1.17 vs -0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and SOXS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer